Express Pharma

Glenmark posts Q2 results, sees growth from US, Indian and Russian markets

0 113

Glenmark Pharmaceuticals Limited (GPL), the research-led global integrated pharmaceutical company announced its results for the second quarter (Q2) ended September 30, 2012. For Q2 ended September 30, 2012, Glenmark’s consolidated revenue was at $227.89 million as against $230.74 million an increase of 18.93 per cent.

Excluding out-licensing income r